Revive Therapeutics Ltd. (RVV.CN)
Develops drugs treating infectious diseases, mental health conditions, and rare disorders
0.03-0.17%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+66.7%
The outlook
Revive Therapeutics trades at $0.025, sitting near its 52-week lows with mixed momentum against its moving averages. Analyst coverage appears thin, and the overall sentiment leans neutral. The stock is in the lower portion of its recent trading range.
What’s behind the score
Price trendMixed vs its moving averages
52-week range27% of the way from its 52-week low to high
Market cap
$10.9M
52-wk high
0.08
52-wk low
0.01
50-day avg
0.03
200-day avg
0.02
Trailing P/E
—